Phoenix Research & Develo is categorized under Drug Abuse Counselor, Nontreatment in Lithonia, GA and active since 1999.
Phoenix Research & Develo was established in 1999, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Drug Abuse Counselor, Nontreatment business, which does work in the B2C market, and is classified as a Drug Abuse Counselor, Nontreatment, under code number 624190 by the NAICS.
If you are seeking more information, feel free to contact Brenda Griffin at the company’s single location by writing to 1701 Limestone Terrace, Lithonia, Georgia GA 30058 or by phoning (770) 388-0178. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Phoenix Research & Develo |
Contact Person: | Brenda Griffin |
Address: | 1701 Limestone Terrace, Lithonia, Georgia 30058 |
Phone Number: | (770) 388-0178 |
Annual Revenue (USD): | $50.000 to $99.999 |
Founded: | 1999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Drug Abuse Counselor, Nontreatment |
SIC Code: | 8322 |
NAICS Code: | 624190 |
Share This Business: |
Phoenix Research & Develo was started in 1999 to provide professional Drug Abuse Counselor, Nontreatment under the SIC code 8322 and NAICS code 624190. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Brenda Griffin for inquiries that concern Phoenix Research & Develo by calling the company number (770) 388-0178, as your correspondence is most welcome. Additionally, the physical location of the single location of Phoenix Research & Develo can be found at the coordinates 33.740199,-84.041891 as well as the street address 1701 Limestone Terrace in Lithonia, Georgia 30058.
For its online presence, you may visit Phoenix Research & Develo’s website at and engage with its social media outlets through on Twitter and on Facebook.